Inovio Product Pipeline: Infectious Diseases

Product & Indication
Selected antigens for various infectious diseases, delivered intramuscularly using Inovio's electroporation technology.

Technical
Wyeth is conducting preclinical tests of selected antigens as therapeutic vaccine candidates for infectious diseases.

Stage of Development
Phase: Pre-clinical product definition.
Purpose: Define clinical candidates.

Commercialization
Vaccine: owned by Wyeth.
Delivery technology: owned by Inovio.